toripalimab,porustobart
junshi biosciences,harbour biomed,coherus
['porustobart', 'toripalimab', 'harbour']
#harbourbiomed announces results of phase ib clinical trial of #porustobart in combination with #toripalimab in advanced high-grade #neuroendocrineneoplasms at #aacr23 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.